Fig. 7: FMD exerts cardio-protection against immunotherapy side effects via attenuating Reactive Oxygen Species (ROS), NLRP-3 inflammasome, leukotrienes and NF-kB expression in heart.

ROS, NLRP-3 inflammasome, leukotrienes and NF-kB expression in heart (A) and plasma (B) (n = 5). Statistical analysis was performed using one-way analysis of variance (ANOVA). Differences were considered significant when P < 0.05. All data are represented as mean ± SEM. Source data are provided as a Source Data file.